1,082 results on '"Nakamura, Y."'
Search Results
2. Incidence of potential candidates for kidney-sparing surgery in upper tract urothelial carcinoma : Analysis using radical nephroureterectomy specimens
3. Prognostic predictors of hypertension outcomes after adrenalectomy in primary aldosteronism
4. Real-world outcomes of first-line systematic treatment in advanced upper urinary tract urothelial carcinoma patients with renal impairment: YUSHIMA-04 study
5. Outcomes of partial and radical nephrectomy in patients with pathological T3a upstaging of clinical T1 renal cell carcinoma: an analysis from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort
6. Comparison of the utility of worst vs. global Gleason grade group in MRI-US fusion biopsy for predicting postprostatectomy biochemical recurrence
7. Tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer: Long-term oncologic outcomes of 201 patients
8. Recurrence monitoring using ctDNA in patients with metastatic colorectal cancer: COSMOS-CRC-03 and AURORA studies
9. Genomic profiling and clinical utility of circulating tumor DNA in metastatic renal cell carcinoma: Nationwide SCRUM-Japan MONSTAR SCREEN project
10. A retrospective multicenter study on the real-world efficacy of chemotherapy in 204 Japanese patients with advanced extra-mammary Paget's disease
11. Prognostic impact of the surgical deep margin distance of invasive acral melanoma of the sole: A multi-institutional retrospective study
12. Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan
13. Corrigendum to “Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer”
14. Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in BRAF V600E-mutated metastatic colorectal cancer: GI-SCREEN post-hoc analysis
15. P2.02-03 Association of irAEs with the Efficacy of PACIFIC Regimen in Patients with Unresectable Stage III NSCLC: WJOG11518L/SUBMARINE
16. Age-related changes in circulating INSL3 concentrations and their associations with ovarian conditions in Japanese Black beef cattle
17. EP04.04-05 Ten-year CTNB Data Indicate Its Usefulness and Safety, Especially Salvage Situation after Bronchoscopy without Diagnosis
18. PB0085 Pitfalls of Complications due to Coagulopathy in Patients with Severe COVID-19 during ECMO: Beware of Bleeding Caused by Acquired von Willebrand Syndrome
19. LB1632 PD-1 signaling plays a critical role for inhibiting development of autoimmune disease-associated dermatitis in childhood
20. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
21. What happens at the interface between tool and workpiece with extremely expanded surface during cold forging
22. 986 Constipation enhances gut-skin axis imbalance in a mouse model of acne vulgaris
23. The energy spectrum of cosmic rays measured by the Telescope Array using 10 years of fluorescence detector data
24. 975 Skin inflammation disrupts intestinal antimicrobial activity and the gut microbiome
25. 726 Plasma membrane phosphatidylinositol 4,5-bisphosphate is required for maintenance of epithelial characteristics in keratinocytes
26. 954 Differential regulation of comedogenesis and folliculitis by free fatty acids metabolized by cutibacterium acnes: Comprehensive analysis of human acne subjects and animal model
27. 955 Skin care improves newborn skin dysbiosis associated with atopic dermatitis
28. 933 Staphylococcus aureus reversibly regulates Agr quorum sensing to cause an outbreak in a hospital
29. 350 Increased LL37 in patients with psoriasis and rosacea promotes the uptake of low-density lipoprotein and development of atherosclerosis
30. 1158 UVC irradiation induces neuropilin-1+ regulatory T cells in skin and lymph nodes
31. P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer
32. P172 Different incidence of brain metastasis according to HER2 expression level in patients with triple negative breast cancer
33. WCN23-0404 SYNERGISTIC ANTI-INFLAMMATORY AND RENAL PROTECTIVE MECHANISMS MEDIATED BY PARASYMPATHETIC AND SYMPATHETIC NERVOUS STIMULATION VIA IMMUNE SYSTEM
34. Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
35. Increases of Plasma Insl3 Concentrations from Calves to Cows and Their Associations with Ultrasonographic Ovarian Measurements in Japanese Black Beef Cattle
36. The strong CP problem solved by itself due to long-distance vacuum effects
37. Development of a radiopaque tiltmeter to improve reproducibility for Fowler's position on chest radiography
38. Development of a targeted gene panel for the diagnosis of Gorlin syndrome
39. 401P A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors
40. 235P Evaluation of a prognostic model for head and neck cutaneous squamous cell carcinoma using a cumulative number of risk factors
41. EP08.02-143 Shortening of the Turn around time (TAT) in the Examination of Rapid On-Site cytologic Evaluation (ROSE) at transbronchial biopsy.
42. 807P Adjuvant anti-PD-1 monotherapy benefit varies across different ethnicities and melanoma subtypes
43. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
44. 809P Outcomes of patients with resected stage III/IV acral or mucosal melanoma treated with adjuvant anti-PD-1 therapy
45. 1705P HER2 intratumoral genetic and non-genetic heterogeneity in metastatic colorectal cancer
46. 531 Cardiovascular comorbidities are associated with increased LL37 which promotes the uptake of low-density lipoprotein into macrophages
47. P-74 SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: Biliary tract cancer cohort (trial in progress)
48. P-156 MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress
49. PD-13 Plasma RAS dynamics and efficacy of anti-EGFR rechallenge in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials
50. Comparison between Raman spectra of carbonaceous material and carbon isotope thermometries in low-medium grade meta-carbonates: Implications for estimation of metamorphic temperature condition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.